Medicine has always aspired to treat the individual. Yet for most of its history, it has treated the average. A drug approved for millions is calibrated to a statistical middle ground — effective for many, suboptimal for some, harmful for a few. That era is drawing to a close. Personalized gene editing is no longer…
